All posts by: Michael Zand

About Michael Zand

Stem cell therapy may mend damaged hearts, says research – Economic Times

Continue reading

2016-04-09

Hindustan Times

Stem cell therapy may mend damaged hearts, says research
Economic Times
Neha Sewani, Dietician, Truweight explains, “Diabetes has not suddenly cropped up but it has made its way slowly and steadily through the changing habits of people who now rely more on the app on their mobile to decide if they have eaten enough rather …
Stem cell therapy could be the new saviour for heart patientsHindustan Times
New heart therapy at U of U saving livesKUTV 2News

all 3 news articles »

Continue reading

2016-04-09

Hindustan Times

Stem cell therapy may mend damaged hearts, says research
Economic Times
Neha Sewani, Dietician, Truweight explains, “Diabetes has not suddenly cropped up but it has made its way slowly and steadily through the changing habits of people who now rely more on the app on their mobile to decide if they have eaten enough rather …
Stem cell therapy could be the new saviour for heart patientsHindustan Times
New heart therapy at U of U saving livesKUTV 2News

all 3 news articles »

Continue reading

2016-04-09

Ottawa Sun

Ottawa Hospital’s experimental new stem cell treatment a world first
Ottawa Sun
Berniqué, a 73-year-old grandfather of five from Hawkesbury, Ont., would become one of the first patients last summer to receive a new and experimental stem cell treatment for septic shock at The Ottawa Hospital. The hospital’s ongoing clinical trial

and more »

Continue reading

2016-04-09

Ottawa Citizen

Ottawa Hospital’s experimental new stem cell treatment a world first
Ottawa Citizen
Berniqué, a 73-year-old grandfather of five from Hawkesbury, Ont., would become one of the first patients last summer to receive a new and experimental stem cell treatment for septic shock at The Ottawa Hospital. The hospital’s ongoing clinical trial

and more »

Continue reading

2016-04-08

Capitol Weekly

Stem cell agency okays $150 million ‘powerhouse’
Capitol Weekly
Directors of California’s stem cell agency this morning approved financing terms for a proposed, $150 million, public-private company that the agency hopes will accelerate the creation of long-sought stem cell therapies. The plan to create a stem cell …